GlassScriptPhysician profile
Zaheer Ahammad
NPI 1205491065
$6,270.01
in general payments reported to CMS, 2019-2025
21 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $1,595 · 2023: $3,914 · 2024: $198 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,728 · Food and Beverage: $1,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,727.97 |
| Food and Beverage | $1,794.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,084.59 | 2023 | Truelok |
| Smith+Nephew, INC. | $1,691.83 | 2021-2025 | Oasis, Grafix, Stravix Pl |
| Mid-Atlantic Surgical Systems, LLC | $1,212.64 | 2022 | |
| Stryker Corporation | $206.25 | 2023 | N/A, Augment Injectable, Ortholoc 3di |
| Bone Support INC. | $150.82 | 2025 | Ceramentbone Void Filler, Cerament G |
| Paratek Pharmaceuticals, INC. | $130.13 | 2025 | Nuzyra |
| Abbvie INC. | $125.00 | 2022 | |
| Integra Lifesciences Corporation | $109.78 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nevro Corp. | $81.37 | 2022-2024 | Senza |
| Organogenesis INC. | $74.83 | 2023 | Puraply |
| Horizon Therapeutics Plc | $64.21 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $60.17 | 2025 | |
| Cardiovascular Systems INC. | $48.91 | 2022 | |
| Averitas Pharma INC. | $48.75 | 2023 | Qutenza |
| Depuy Synthes Sales INC. | $36.98 | 2024 | Motoband, Na, Motoband Cp |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $33.12 | 2025 | Matriderm |
| Solventum Corporation | $29.78 | 2024 | Prevena, V.A.C. Veraflo |
| Alexion Pharmaceuticals, INC. | $22.79 | 2023 | Strensiq |
| Treace Medical Concepts, INC. | $22.25 | 2024 | |
| Aroa Biosurgery Incorporated | $19.70 | 2024 | |
| Bioventus LLC | $16.11 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaheer Ahammad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.